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Assessment and management of shock; a nursing perspective

Shock is a life-threatening condition (Hand, 2001). It is vital therefore that all nurses are able to recognise its clinical presentation, and respond promptly and appropriately. This article aims to address these issues by firstly examining the pathophysiology and stages of shock associated with different aetiologies, and then analysing the current evidence base underpinning a variety of multi-professional interventions. A systematic search of the literature was undertaken using the CINAHL, MEDLINE and Cochrane library databases between the years of 1999-2004. The keywords shock, fluids, inotropes combined with nurse assessment, intervention and management were used. The results of this search have been used to inform the discussion throughout.   

Shock can be defined as a mean arterial blood pressure (MABP) inadequate to meet the needs of the tissues (Tortora and Grabowski, 2003). MABP is the average blood pressure over the whole of the cardiac cycle and reflects global tissues perfusion (Tortora and Grabowski, 2003). Inadequate MABP results in an imbalance whereby the demand for oxygen is not met by oxygen delivery. This is a relative state, and thus there is no specific MABP at which shock occurs. However, it is generally acknowledged that a MABP of less than 60mmHg inhibits renal, coronary and cerebral perfusion (Thelan et al, 1998). In some patients however (e.g. those normally with hypertension), a much higher MABP may be required (Schulman, 2003).    

Shock has a variety of aetiologies, which can be divided into three main groups: pump failure (cardiogenic), intravascular fluid depletion (hypovolaemic), and vasodilation of the systemic system (distributive) (Hand, 2001). However, the end result of all of these is a low MABP and inadequate tissue perfusion. The analogy of a central heating system can be used to explain this (Figure 1). 

Assessing the patient in shock
The clinical presentation of the patient will depend upon the originating cause, and the stage of shock with which they are presenting. Many authors identify three stages. These are: compensated, progressive and decompensated or irreversible (Hand, 2001). However, depending on the underlying pathology, and on the age and premorbid status of the patient, these stages may not always be clearly definable, due to an inability to compensate (Schulman, 2003). (See case study 1 for an example).

Hypovolaemic shock  
Hypovolaemic shock is caused by an inadequate intravascular volume (McLuckie, 2003). This can be due to loss of blood or other body fluids (McLuckie, 2003). If the fluid loss is less than 750mls, the patient will usually present with a compensated picture whereby the body tries hard to make up for the loss of fluid in the system(McLuckie, 2003). Compensation occurs by an increase in heart rate and systemic vasoconstriction. These two mechanisms maintain MABP in order to optimise perfusion to vital organs such as the brain and the heart. They are triggered by an increase in sympathetic activity and the release of catecholamines (adrenaline and noradrenaline) (Tortora and Grabowski, 2003). Further compensatory mechanisms are initiated by the kidney, due to the reduced renal blood flow and adrenaline secretion (see Figure 2), and antidiuretic hormone (ADH) is released from the posterior pituatory gland when osmoreceptors detect an increased concentration in the intravascular fluid. These mechanisms result in vasoconstriction (angiotensin II) and an increase in sodium and water reabsorption (aldosterone and ADH) via the kidneys  (Tortora and Grabowski, 2003). 

The result of these early compensatory mechanisms is seen in the clinical presentation of the patient, the signs, symptoms and causes of which are listed in Table 1.   At this stage the patient is usually able to maintain a normal systolic pressure, MABP, and central venous pressure (CVP) as venous return to the heart (preload) is maintained, but renal and gut perfusion are affected leading to oliguria and nausea.
 
Vigilance by nursing staff for what can be very subtle alterations is essential. Regular observations of heart rate/pulse, core and peripheral temperature, blood pressure (including MABP), central venous pressure (CVP) or jugular venous pressure (JVP), respiratory rate and urinary output should be performed. Adequate urine output is considered to be >0.5mls/kg/hour (Woodrow, 2000). Nursing assessment also involves the recording of peripheral oxygen saturation (Sp02). However, this can be unreliable as the patient may have inadequate peripheral perfusion to ensure a reliable trace. Additionally, as this tool estimates oxygen availability by identifying the percentage of haemoglobin (Hb) saturated with oxygen, if large amounts of blood have been lost then saturations may read high despite there being inadequate oxygen available (Casey, 2001). An arterial blood gas may therefore be indicated for accurate assessment. Blood sampling for urea and electrolyte levels, full blood count and glucose levels will further add to the assessment data. The patient will often present with elevated glucose levels due to cortisol release as part of the stress response, and this results in an increased sensitisation of the tissues to catecholamine activity (Tortora and Grabowski, 2003).

The nurse will need to have a good knowledge of the patient’s history and potential causes of hypovolaemia. Common causes include blood or fluid loss following trauma, surgery, dehydration due to diarrhoea, vomiting or inadequate intake, and fluid shifts due to factors such as ascites and severe systemic infection. A full assessment of the patient should be undertaken to identify any signs of these. 

If fluid loss continues or if the situation is not resolved, the body is unable to maintain its compensatory mechanisms, and signs of inadequate tissue perfusion will become evident. These may include a rising serum lactate level (normal levels <1.3) producing a metabolic acidosis, low arterial oxygen content, chest pain, cardiac dysrhythmias, an altered level of consciousness and possible anuria (McLuckie, 2003). At this point the patient would be unable to maintain an adequate MABP without assistance, and is at risk of cardiopulmonary arrest. 

As the aetiology of hypovolaemic shock is related to fluid loss, then in addition to the early delivery of adequate oxygen therapy, fluid replacement is clearly the most appropriate form of treatment to instigate. Although prescription of fluid is outside of the nursing remit, it is important for the nurse to understand the advantages, limitations and associated implications of different fluid types (NMC, 2002a; NMC, 200b), as nurses are commonly responsible for administering and evaluating the effects of fluid administration.  In order to ensure adequate fluid resuscitation, venous access appropriate to fluid requirements should be established (e.g. central line or large peripheral cannulae), and a urinary catheter inserted to monitor output.

In order to evaluate the effectiveness of the fluid therapy, and monitor for any adverse reactions, repeated measures of at least MABP +/- systolic and diastolic BP, urine output, heart rate, temperature, respiratory rate and capillary refill time (CRT), which should be <3seconds (Epstein et al, 2003), should be performed. If a patient has a central line in situ, CVP measurements can also be made before and after the administration of fluid. A sustained CVP rise usually indicates that the patient is adequately filled, regardless of the initial value (Treacher, 2003). Furthermore, accurate fluid balance should be monitored and documented, and repeated blood samples for Hb and haematocrit (HCT)/Packed Cell volume (PCV) taken. 

Blood transfusion
If the patient has lost whole blood then infusion of blood products is indicated. Optimal Hb levels will depend on the individual patient and their circumstances, but need to ensure adequate oxygen carrying capacity. Although a normal Hb is considered to be in the range of 12-18g/dl, it is generally accepted that lower concentrations decrease blood viscosity and so aid perfusion (Woodrow, 2000). For critically ill patients the target Hb can be as low as 7-8g/dl (Hebert et al, 1999; Corwin et al, 2003; Hill et al, 2004), although some patients, such as those with active ischaemic cardiac disease may require this to be higher (Hebert et al, 2001). In addition, the HCT or PCV gives an indication of the concentration of red blood cells in the plasma. A raised HCT/PCV suggests that the patient has a higher percentage of red blood cells in relation to plasma fluid and thus infusion of further blood products may not be indicated at this point. 

Blood transfusion has recognised adverse effects including potential infection and allergic reaction (Hill et al, 2004). Nurses must check blood products carefully to ensure correct patient, blood group and antibody status. Blood should be stored according to local guidelines and transfusions administered according to the prescription whilst observing closely for signs of a transfusion reaction (British Committee for Standards in Haematology, 1999). Clinical symptoms of a reaction might include a rise in temperature, local or generalised urticaria, and a rash (Bywater and Rawlings, 2003). If any of these signs are present, the blood should be stopped immediately, and the event reported to the doctor. Documentation of the event should also be undertaken and the unit of blood returned to the laboratory for analysis. The nurse should also be aware of the higher levels of sodium and potassium, which might be present in packed cells. This could cause problems such as cardiac arrythmias, fluid overload and respiratory distress particularly in patients with cardiac and/or renal disease. These problems are most likely to occur with multiple transfusions, and the prescription of diuretics may then be indicated to prevent their occurrence (Edwards, 2001). Coagulation deficits might also become apparent with multiple transfusion requiring the administration of fresh frozen plasma (FFP).

Crystalloids and colloids
If blood products are not required, then fluid replacement will consist of either a crystalloid or colloid solution (see Figure 3 for examples). There has been much debate over recent years as to which of these is preferable (Rizoli, 2003). In a systematic review initially conducted by the Cochrane Library in 2001, no evidence was found to support the use of colloids over crystalloids in the critically ill patient (Alderson et al, 2004). There has however been some criticism since aimed at this review (Horsey, 2002), and the choice of fluid remains a clinical decision based on individual patient requirements and response. 

Crystalloid solutions 
Crystalloids have been described as “balanced salt solutions that freely cross capillary walls” (O’Neill and Perrin 2002), and thus remain in the intravascular compartment for a relatively short period of time. They are made up of water and electrolytes, and include products such as sodium chloride, dextrose, Hartmanns and Ringers lactate solution. The type of crystalloid prescribed for a patient will depend upon which fluid compartment is being targeted. The disadvantage of using crystalloid to treat hypovolaemic shock is that relatively large amounts of fluid will be required to elicit a response (Bradley, 2001). This could be problematic in certain groups of patients such as those with cardiac dysfunction, and the nurse should be vigilant for signs of peripheral and pulmonary oedema (Bradley, 2001). Despite these limitations, advocates of crystalloid therapy argue that they are comparatively cheap, and avoid the complications associated with other products.

Colloids
Colloids include solutions such as albumin, gelatins, dextran and starches. They have larger molecules than crystalloids, and have the ability to increase oncotic pressure. This means that they will remain in the intravascular space for longer, and draw in additional water from the interstitial space i.e. plasma expanders (Bradley, 2001). Smaller volumes of fluid are also required to achieve a rise in MABP. However, colloids have been associated with a variety of problems including infection, anaphylactic reactions and clotting problems (Bradley, 2001). There have also been reports of the movement of colloids into the interstitial space, particularly in critically ill patients, resulting in fluid shifting out of the intravascular compartment, and a further reduction in MABP (Alderson et al, 2004). Furthermore, colloids are relatively more expensive than crystalloids. Bunn et al (2004) found no evidence in their systematic review of any advantages of one colloid over another, although did note that confidence intervals were wide, reducing the validity of the findings. Newer products such as hypertonic saline dextran (HSD) are now available, which have attempted to overcome the disadvantages of both groups (Bradley, 2001), but these as yet have failed to become commonplace in practice settings within the United Kingdom (U.K.).    

Cardiogenic shock
The presentation of a patient with cardiogenic shock is very similar to that of hypovolaemia. However, as the myocardium is not able to function effectively, compensatory mechanisms are hindered, leading to a more rapid progression through the stages of shock. The failing left ventricle results in inadequate cardiac output, and the increase in systemic vasoconstriction increases afterload (resistance against which the heart has to pump) making it even harder for the left ventricle to achieve an adequate cardiac output and blood pressure (McLuckie, 2003). This can result in backflow of blood into the lungs causing pulmonary oedema recognised by acute dyspnoea, hypoxaemia and a cough. Crackles can also be heard throughout the chest on auscultation. CVP/JVP will be elevated due to this increased pressure and right heart congestion (McLuckie, 2003). As a result of poor cardiac output, there is decreased coronary perfusion resulting in chest pain, and decreased systemic perfusion resulting in symptoms of organ impairment such as altered consciousness, poor urine output, and nausea and vomiting.

Mortality rates for patients with cardiogenic shock remain between 50-80% despite intervention (Bromet and Klein, 2004), and so nurses caring for such patients should be highly vigilant for early symptoms. Common causes are acute events such as myocardial ischaemia, infarction, complex cardiac dysrhythmias, and chronic left ventricle failure due to conditions such as cardio-myopathy. Cardiac events may not always be initially obvious, but the nurse should be alert for potential signs especially if the patient has an underlying cardiac history and/or has been subject to either physiological or psychological stress (e.g. trauma, surgery). This may involve cardiac monitoring, performing a 12 lead electrocardiogram (ECG), or ensuring blood samples for cardiac enzymes/troponin levels are sent for analysis where appropriate, as well as the other observations discussed earlier under hypovolaemic shock. 

In contrast to hypovolaemia, the patient with cardiogenic shock has a problem with the ability of the heart to pump effectively. Management strategies are therefore primarily aimed at the improvement of contractility and therefore blood pressure, and treatment of secondary problems such as pulmonary oedema and cardiac ischaemia.  Commonly, treatments of choice for these patients include the use of diuretics, inotropic and vasodilator agents to reduce cardiac workload, invasive procedures such as percutaneous transluminal coronary angioplasty (PTCA), thrombolytic therapy, coronary artery bypass grafting (CABG), mechanical support of the heart such as intra-aortic balloon pumping (IABP) or less commonly ventricular assist devices (VAD) (Hochman et al, 2000). The majority of these patients will require relocation to a high dependency/ intensive care unit. Oxygen therapy at an early stage is important to prevent further cardiac ischaemia and associated chest pain. Analgesics such as diamorphine or morphine are often used as they improve coronary perfusion by dilating the coronary vessels, and help to relieve associated pain and anxiety. Assessment of respiratory function following administration of opiates, as well as correct administration of a controlled drug should be considered, as well as the need for an anti-emetic to prevent associated nausea. As with hypovolaemia, fluid balance must be accurately monitored, and frequent 12 lead ECG readings must be performed in addition to continuous cardiac monitoring. The patient may have their cardiac output measured invasively using a pulmonary artery catheter or other similar device.

Inotropic agents     
The purpose of using an inotropic drug in a patient with cardiogenic shock is to improve the ability of the myocardium to contract effectively and to reduce the resistance against which the heart has to pump (afterload). Agents with both these properties include dobutamine, milrinone or more recently levosimendon (Delle Karth et al, 2003). However, these drugs may themselves cause further drops in blood pressure and so alternatives may need to be selected. Patients receiving such drugs should have ECG monitoring and be under close observation in a critical care unit, with their blood pressure monitored continuously via an arterial line. Drugs should be administered via a dedicated central venous catheter lumen, and should not be stopped abruptly. Glyceryltrinitrate (GTN) may also be prescribed to relieve pain and reduce preload and afterload by vasodilation, but again this may cause a drop in blood pressure, and so requires careful titration against the patient’s haemodynamic parameters. Nurses caring for such patients have a responsibility to ensure they have undergone appropriate training, and are aware of the possible adverse effects associated with these drugs (NMC, 2002b).  

Distributive shock 
Shock caused by a reduction in systemic vascular resistance (SVR) is the most complex to understand, and differs in its presentation as the patient is unable to mount a normal compensatory response. Whether this is due to systemic infection, anaphylaxis or spinal nerve damage, the defining feature is that the patient will feel peripherally warm due to vasodilation rather than cool as in the other types discussed (Hand, 2001). This results in an inability to maintain MABP and so the patient presents with early signs of inadequate tissue perfusion.  The heart attempts to compensate for the severe reduction in preload by increasing the heart rate, resulting in the patient presenting with tachycardia in both septic and anaphylactic shock. This tachycardia is worsened by the initiation of the inflammatory response. However, in neurogenic (spinal) shock, sympathetic drive is lost due to damage to the spinal nervous system and the patient may present with a bradycardia (Hand, 2001). Once again, a priority for the nurse is to be aware of early symptoms relevant to the underlying physiology. 

Septic shock
For sepsis these might include a rising core temperature, white blood cell count or C-reactive protein(CRP), and/or a history to support the potential development of sepsis (e.g. bowel surgery, severe malnutrition, multiple antibiotic therapy, immunosuppresant therapy  or prolonged hospital admission). In 1992 a consensus conference defined septic shock as “…sepsis induced hypotension despite adequate fluid resuscitation along with the presence of perfusion abnormalities” (Bone et al 1992: 25), and identified strict diagnostic criteria which still apply today (Dellinger, 2003) (see Table 2). Septic shock can also trigger the coagulation cascade leading disseminated intravascular coagulation (DIC), and therefore signs of clotting dysfunction such as APTT/INR and platelets should be closely monitored for abnormalities. Furthermore, due to an increase in capillary permeability as a result of inflammatory cytokine activity, and the movement of fluid into the interstitial space, the patient is at risk of developing a secondary hypovolaemia (McLuckie, 2003).

The treatment for septic shock is aimed at identifying and treating the causative organism although in practice this often proves difficult to achieve. Blood cultures are taken and antibiotic therapy prescribed with this in mind. The cardiovascular system often requires support in the form of adequate oxygen and inotropic therapy, although in contrast to cardiogenic shock drugs of choice are those which have a primarily vasoconstrictive effect (e.g. noradrenaline). In addition, fluid administration is often required to compensate for vasodilation. Advanced respiratory support (e.g. ventilation) is often required and such patients require transfer to a critical care environment. As well as managing numerous advanced therapeutic interventions, nursing priorities of care include strict attention to the use of universal precautions and prevention of secondary infection. The patient will often present with a pyrexia and may be prescribed antipyretic therapy, although consideration needs to be given to the importance of the stage of fever, and the metabolic status of the patient before administering such drugs (Henker, 1999). Patients may complain of feeling hot or cold, and additional blankets, or other warming or cooling methods may be considered, although there is debate over the relative advantages and disadvantages of many of these therapies (Henker, 1999), and each patient needs to be assessed individually prior to any intervention.    
Anaphylactic shock
Analphylactic shock presents suddenly and is an emergency situation requiring prompt intervention to prevent cardio-respiratory arrest. Symptoms include angio-oedema, dyspnoea, cardiac dysfunction, generalised rash, urticaria and gastro-intestinal disturbances e.g. nausea and vomiting (Resuscitation Council U.K., 2002; Hand, 2001) and/or a history of allergic reaction e.g. asthma, drug reactions and food allergies. Additionally, the ability to increase oxygen delivery to the tissues may be hindered by bronchial constriction presenting as potential airway obstruction (Resuscitation Council U.K., 2002). Guidelines for its treatment are given by the Resuscitation Council (Resuscitation Council U.K., 2002), and include the intramuscular administration of 0.5mg of 1:1000 adrenaline (0.5ml). Potential causes (e.g. drugs) should be identified and removed where possible, and appropriate medical support summoned urgently. High flow oxygen at the maximum percentage available (usually 85%) should be administered to the patient, and intravenous access should be established. The patient may be prescribed an antihistamine, and a steroid to reduce the effects of the inflammatory response. Fluid therapy might also be indicated to improve the blood pressure, and a cardiac monitor should be attached to the patient to observe for any cardiac dysrhythmias which could occur as a result of the anaphylaxis. If a patient progresses to cardio-respiratory arrest then the resuscitation council guidelines for basic/advanced cardiac life support must be followed. All nurses have a professional responsibility to ensure that they are able to provide at least basic life support (Resuscitation Council U.K., 2000).      

Neurogenic shock
This form of shock is less common than the others described, but should be considered in any patient with a suspected spinal injury or who has received spinal anaesthetic agents (e.g. epidurals). Treatment includes fluid therapy and the use of vasoconstrictor agents to compensate for the loss of sympathetic activity. Adequate oxygen therapy should be administered, and the patient may require drug therapy to treat any bradycardia. There is an increased risk of deep vein thrombosis due to venous pooling (Hand, 2001), and so the nurse should be vigilant for signs of this. Regular neurological assessment using the Glasgow coma score (GCS) is also important, especially if associated with cerebral damage. At all times the patient should be closely monitored for further deterioration.

The nursing role in managing the patient with shock   
Regardless of the precipitating cause of shock, if left untreated, the patient will progress to a situation of inadequate tissue perfusion and organ failure (Tortora and Grabowski, 2003). Initial interventions should therefore be aimed at optimising oxygen delivery to all organs. Common interventions include adequate oxygen, fluid and/or drug therapy. In all cases the nurse needs to provide a safe environment for the patient who may be at risk due to a reducing level of consciousness and deteriorating vital signs. Close monitoring of vital signs are necessary. The frequency of these will depend upon the stability of the patient, with continuous monitoring being instigated for a patient at risk of rapid deterioration. The nurse must be aware of when observations are abnormal for the individual patient, and who to call for assistance. This might be aided by the use of early warning trigger scores, and/or close liaison with the critical care outreach team, if such a team is available (DoH, 2000). The nurse should also ensure that all emergency equipment (e.g. resuscitation trolley, suction and oxygen) is checked to be available and working, and that potential users are competent in its use. Location of the patient should be considered to ensure that they can be closely observed. This may involve the transfer of the patient to nearer the nurses’ station or a higher level of care, such as a high dependency unit (DoH, 2000). Psychological care of the patient and family is also a vital component. Anxiety management is a key part of the treatment of the patient in shock as there is a direct link between anxiety and the initiation of the stress response (Tortora and Grabowski, 2003). Anxiety could be related to a fear of death, the degree of technical equipment around the bedside, and the discomfort of critical illness. Information regarding their condition and any interventions should be provided, and an open, honest and supportive relationship developed between the nurse, patient and their loved ones. 

Other important nursing considerations relate to the maintenance of skin integrity, which is put at risk by poor perfusion and immobility, adequate nutritional intake as the gastro-intestinal tract may be not be functioning, and monitoring serum full blood count, clotting and urea, creatinine and electrolyte levels which may become disrupted due to fluid loss and/or renal impairment. Increases in potassium for example may cause cardiac dysrhythmias, and a low haemoglobin (Hb) will reduce oxygen carrying capacity, further limiting the degree of oxygen delivery to tissues (Casey, 2001). Oxygen therapy should be prescribed, titrated against oxygen saturation and/or arterial blood gas results, and must be administered according to prescription and local protocol. Humidification will also help prevent secondary complications such as sputum retention and chest infection.

A reduced level of consciousness and deteriorating state will mean the patient is unable to attend to their personal hygiene needs, and will therefore need assistance. Effective oral hygiene is essential to ensure comfort, avoid a dry mouth due to oxygen therapy, and to prevent the development of oral and systemic infection. The position in which the patient is nursed also needs careful thought. If conscious level and MABP allows, the patient should be nursed head up or in a lateral position to facilitate adequate ventilation. Supine positioning should be avoided whenever possible due to the increased risks of aspiration and secondary infection (Scolapio, 2002). 

Conclusion 
This article has provided an overview of the aetiology of different types of shock, and the nursing role in the assessment and management of such patients has been considered throughout. It is important to remember that if prompt recognition and management of symptoms is not instigated, the patient may progress to the irreversible stage of shock whereby organ damage does not respond to treatment and death becomes imminent (Hand, 2001). Nurses, who are in continuous attendance with the patient, are in a prime position to ensure that this is avoided, and that outcome for the patient is optimised. This requires not only accurate assessment and management skills, but the integration of these with a good understanding of the underlying physiology associated with shock, and its different aetiologies. Key interventions for all types of shock are focused around adequate oxygen therapy, appropriate fluid and drug therapy and close patient monitoring. Furthermore, effective communication with the rest of the inter-professional team is vital to ensure that collaborative practice maximises the quality of patient care delivered.  
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